Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Pharmacol Biochem Behav. 2013 Nov 15;0:31–42. doi: 10.1016/j.pbb.2013.11.008

Table 2.

Summary of Studies with 5-HT1A Receptor Active Drugs on Sexual Behavior

Drug Receptor Action Route Behavior Examined Effect References
8-OH-DPAT 5-HT1A agonist peripheral lordosis decrease (Fernandez-Guasti et al., 1987; Hebert et al., 1995; Snoeren et al., 2010; Snoeren et al., 2009; Snoeren et al., 2011b)
ipsapirone 5-HT1A agonist peripheral- hi dose lordosis decrease (Mendelson and Gorzalka, 1986)
ipsapirone 5-HT1A agonist peripheral- low dose lordosis increase (Mendelson and Gorzalka, 1986)
gepirone 5-HT1A agonist peripheral- hi dose lordosis decrease (Mendelson and Gorzalka, 1986)
gepirone 5-HT1A agonist peripheral- low dose lordosis increase (Mendelson and Gorzalka, 1986)
buspirone 5-HT1A agonist peripheral- hi dose lordosis decrease (Mendelson and Gorzalka, 1986)
buspirone 5-HT1A agonist peripheral- low dose lordosis increase (Mendelson and Gorzalka, 1986)
WAY 100635 5-HT1A antagonist peripheral lordosis increase (Kishitake and Yamanouchi, 2004)
8-OH-DPAT 5-HT1A agonist ic-hypothalamus lordosis decrease (Gonzalez et al., 1997; Uphouse et al., 1992b)
WAY 100135 5-HT1A antagonist ica-hypothalamus lordosis increase (Uphouse et al., 1996a)
8-OH-DPAT 5-HT1A agonist ic-PAGb lordosis decrease (Uphouse et al., 1992a)
8-OH-DPAT 5-HT1A agonist ic-POAc lordosis modest decrease (Gonzalez et al., 1997; Uphouse and Caldarola- Pastuszka, 1993; Uphouse et al., 1992b)
8-OH-DPAT 5-HT1A agonist ic-POA-AHd lordosis- hamsters decrease (Caldwell and Albers, 2002)
8-OH-DPAT 5-HT1A agonist ic-DRNe lordosis no effect (Uphouse et al., 1992a)
8-OH-DPAT 5-HT1A agonist ic-MRNf lordosis decrease (Uphouse et al., 1994)
buspirone 5-HT1A agonist ic-hypothalamus lordosis decrease (Uphouse et al., 1992b)
5-OH-DPAC 5-HT1A agonist ic-hypothalamus lordosis decrease (Uphouse et al., 1993)
5-MEO-DPAC 5-HT1A agonist ic-hypothalamus lordosis decrease (Uphouse et al., 1993)
8-OH-DPAT 5-HT1A agonist peripheral pacing time with male decrease (Snoeren et al., 2010)
a

ic-intracranial;

b

PAG-periaqueductal gray;

c

POA-preoptic area;

d

AH-anterior hypothalamus;

e

DRN-dorsal raphe;

f

MRN-median raph